We investigated the induction and physiological role of Ser20 phosphorylation of p53 in response to DNA damage caused by ionizing radiation (IR) or ultraviolet radiation (UV). A polyclonal antibody that speci®cally recognizes a p53 peptide containing phosphorylated Ser20 was generated and used to detect p53 phosphorylation at Ser20. Western blot analyses of p53 in four cell lines with this antibody revealed that the p53 protein was phosphorylated at Ser20 to a dierent extent after treatment with IR or UV. The phosphorylation of Ser20 of wild-type p53 correlated with enhanced induction of the p53 downstream target genes p21 WAF1/Cip1 (p21) and mdm-2. These results suggest that DNA damage-induced phosphorylation of p53 at Ser20 enhances the transactivation function of p53 for p21 and mdm-2 in vivo.
Introduction
The p53 tumor suppressor, one of the most important cellular sensors and signal transduction ampli®ers, is modi®ed post-translationally and subsequently activated in response to various forms of cellular stress, such as DNA damage, hypoxia, and oncogenic stimuli (reviewed by Giaccia and Kastan, 1998; Prives, 1998) . The p53 protein transcriptionally upregulates the expression of downstream target genes, such as p21 WAF1/Cip1 (p21), 14-3-3g, bax, and fas/APO-1, which relay signals that mediate the inhibition of cell growth or the induction of programmed cell death (reviewed by El-Deiry, 1998) .
Extensive studies have established that the transactivation domain of p53, which interacts with the basal transcription machinery, is located within the Nterminus (reviewed by Giaccia and Kastan, 1998; Prives, 1998) . Within the transactivation domain, the amino acids Phe19, Leu22 and Trp23 residues are required for direct interaction of p53 with the TATAassociated factors TAFII70 and TAFII31/32, both of which are subunits of TFIID (Lu and Levine, 1995; Thut et al., 1995) . In addition, the residues Phe19, Trp23 and Leu26 of p53 interact with Mdm-2, a nuclear protein whose expression is also induced by p53 (Wu et al., 1993) . This interaction abrogates p53 transactivation by directly blocking the interaction of p53 with members of the basal transcription machinery (Oliner et al., 1993; Wu et al., 1993; Kussie et al., 1996; Uesugi and Verdine, 1999) . Mdm-2 also targets p53 for degradation by the ubiquitin-dependent 26S proteasome (Haupt et al., 1997; Honda et al., 1997; Kubbutat et al., 1997) and suppresses p53-mediated growth arrest and apoptosis (Chen et al., 1996; Hsieh et al., 1999) . Hence, the transactivation domain serves as a key site for p53's function. Notably, there are several potential phosphorylation sites around the amino acid residues that have direct contact with Mdm-2 and the TATAassociated factor proteins (Ser15, Thr18, Ser20). The physical location of these phosphorylation sites points to the possible role of phosphorylation in the regulation of p53's function as a transcriptional regulator.
Indeed, all three sites have been shown to be phosphorylated using phosphorylation site-speci®c antibodies (Banin et al., 1998; Canman et al., 1998; Chehab et al., 2000; Dumaz et al., 1990; Higashimoto et al., 2000; Hirao et al., 2000; Sakaguchi et al., 2000; Shieh et al., 2000; Tibbetts et al., 1999; Woo et al., 1998; Jabbur and Zhang, unpublished results) . Use of one such antibody demonstrated that Ser15 phosphorylation after DNA damage by ionizing radiation (IR) or ultraviolet radiation (UV) attenuates the interaction of p53 with Mdm-2 and upregulates p53 binding to the transcriptional co-activator cAMP-response elementbinding protein (CBP) or p300 Siliciano et al., 1997; Lambert et al., 1998) . During the course of our study, several research groups (Chehab et al., 1999; Shieh et al., 1999; Unger et al., 1999) reported that Ser20 is phosphorylated in response to IR, and that the phosphorylation of Ser20 may attenuate the interaction of p53 with Mdm-2. Recently, Thr18 was also shown to be phosphorylated in response to treatment with IR (Dumaz et al., 1999; Higashimoto et al., 2000; Sakaguchi et al., 2000; Jabbur and Zhang, unpublished results) . These ®ndings highlight the speci®city of stress-induced multifunctional regulation of p53 by phosphorylation and provide an insight into the physiological signi®cance of multiple phosphorylation sites on the transactivation domain.
Numerous protein kinases have been shown to phosphorylate human and mouse p53 in vitro at residues known to be modi®ed in response to cellular DNA damage. These include CKI on Ser6, Ser9 and Thr18 (Dumaz et al., 1999; Sakaguchi et al., 2000; Higashimoto et al., 2000) , CKII and p38 MAPK on Ser392 (Meek et al., 1990; Huang et al., 1999; Keller et al., 1999) , p38 MAPK on Ser33 and Ser46 (Bulavin et al., 1999) , ATM on Ser15 (Banin et al., 1998; Canman et al., 1998) , ATR and DNA-PK on Ser15 and Ser37 (Woo et al., 1998; Tibbetts et al., 1999) , Cds1/Chk2 on Thr18 (Shieh et al., 2000) , Chk1 and Cds1/Chk2 on Ser15, Ser20 and Ser37 (Chehab et al., 2000; Hirao et al., 2000; Shieh et al., 2000) and JNK1 on mouse Ser34, whose human homolog is Ser33 (Milne et al., 1995) , which is also phosphorylated by CAK (Ko et al., 1997) .
In this study, we examined the induction of Ser20 phosphorylation of p53 in response to DNA damage caused by IR or UV and the physiological role of Ser20 phosphorylation in enhancing the transcriptional activation function of p53 in vivo. To test the role of Ser20, we generated a polyclonal antibody that speci®cally recognizes the phosphorylated form of p53 at Ser20. With this antibody, we found that Ser20 is phosphorylated in response to DNA damage caused by IR and UV, although the relative extent of Ser20 phosphorylation by UV treatment varies among cell lines. Moreover, we observed that Ser20 phosphorylation correlated with an enhanced expression of p21 and Mdm-2 in treated cells. Hence, these results provide data suggesting that DNA damage-induced phosphorylation of p53 at Ser20 enhances the transactivation function of p53.
Results
To demonstrate the in vivo phosphorylation states of p53 at Ser20, a 10-amino-acid p53 peptide containing phosphorylated Ser at 20 was used to generate a polyclonal antibody (PAbSer20P). This antibody demonstrated speci®c recognition for dot-blotted Ser20-phosphorylated p53 peptide (Figure 1a ). This recognition was abolished upon competition with Ser20-phosphorylated peptide, but not upon competition with Ser20 peptide (Figure 1b ). In addition, PAbSer20P antibody failed to recognize nonphosphorylated or phosphorylated Ser15 and Thr18 peptides, as well as two randomly generated peptides containing phosphorylated Ser or Thr residues ( Figure  1c) . Shieh et al. (1999) , using a dierent polyclonal antibody generated against a Ser20 phosphorylated peptide, demonstrated Ser20 phosphorylation in CEM leukemia cells in response to treatment with IR but not UV. To demonstrate PAbSer20P antibody speci®city for p53 phosphorylated at Ser20 in vivo and to compare our antibody with the phosphoserine-20 speci®c antibody used by Shieh et al. (1999) , we subjected protein extract isolated from IR-or UVtreated CEM cells to immunoprecipitation for p53 protein under nonreducing conditions, using the p53-speci®c monoclonal antibody PAb421. The precipitates were subjected to electrophoresis on a nonreducing SDS ± PAGE gel, transferred to membrane and analysed by Western blotting for the expression of total p53 protein by DO-1 antibody or p53 phosphorylated at Ser20 by PAbSer20P antibody. As Figure  1d shows, PAbSer20P antibody recognized p53 protein isolated from IR-treated cells with and without competition using Ser20 peptide, but failed to recognize phosphatase-pretreated p53, p53 assayed in competition with Ser20-phosphorylated peptide on p53 isolated from UV-treated CEM cells. These experiments demonstrated that PAbSer20P antibody speci®cally dierentiated the in vivo phosphorylation status of p53 at Ser20. We noted that the p53 protein in CEM cells is mutant and de®cient in transcription for p21 (data not shown). Moreover, the inducibility of Ser20 phosphorylation by IR or UV may be cell linedependent. Therefore, we expanded our examination of the in vivo phosphorylation states of Ser20 in wildtype (wt) p53-containing BV173 leukemia, MCF7 breast carcinoma cells and A549 lung carcinoma cells after IR and UV. The presence of wt p53 in these cell lines also allowed us to evaluate the impact of Ser20 phosphorylation on the transactivation function of p53, as assessed by analysing the expression levels of p21 and Mdm-2. ). Thirty minutes after treatment, total protein was extracted from treated cells or control cells under nonreducing conditions. P53 protein from the same amount of total protein was immunoprecipitated. After centrifugation and wash, the precipitates were eluted in nonreducing sample buer or treated with phosphatase (and subsequently eluted), fractionated by SDS ± PAGE and subjected to Western blot analysis with PAbSer20P antibody in the presence or absence of competing peptide, or DO-1 antibody for total p53 protein. C, control; IP, immunoprecipitation Three hours after treatment with IR or UV, total protein from BV173 cells was isolated and analysed by Western blotting for the induction of total p53 protein by DO-1 antibody and for the expression of p21 protein. The functional state of the p53 protein was assessed by analysing the expression levels of p21. As shown in Figure 2a , p53 protein was present at low levels in the untreated cells and accumulated rapidly (within 3 h) after treatment with IR and UV. In contrast, strong induction of p21 protein and mRNA expression was detected only in IR-treated cells, whereas UV-treated cells had relatively low levels of p21 protein and mRNA induction (threefold) (Figure  2a,b) . Then, we examined whether p21 transcriptional upregulation induced by genotoxic stress correlated with phosphorylation of p53 at Ser20.
At 30 min, 1, 2 and 3 h after treatment with IR or UV, total protein was extracted from BV173 cells. These extracts, and extract obtained from nontreated BV173 cells, were subjected to immunoprecipitation for p53 protein under nonreducing conditions using PAb421 antibody and protein G-Agarose. The precipitates were subjected to electrophoresis on a nonreducing SDS ± PAGE gel, transferred to membrane and analysed by Western blotting for the phosphorylation of p53 at Ser20 by PAbSer20P antibody and total p53 protein by DO-1 antibody (Figure 2c,d) . Consistent with the Western blotting results (Figure 2a ), immunoprecipitated p53 protein accumulated rapidly after treatment with both IR and UV. However, only IR-induced p53 protein demonstrated signi®cant levels of Ser20 phosphorylation; phosphorylation occurred at a high rate and intensity (Figure 2d ). The basal level of p53 protein in untreated BV173 cells, as detected by PAbSer20P antibody, was not phosphorylated at Ser20 (Figure 2e ), providing further evidence that Ser20 phosphorylation is induced.
Our ®ndings from IR-and UV-treated BV173 cells demonstrated that the induced phosphorylation of p53 at Ser20 preferentially occurred upon treatment with IR, and that phosphorylation at Ser20 was not required for p53 stabilization in UV-treated BV173 cells. Moreover, the induction of p21 by IR, but not by UV, in BV173 cells suggested that phosphorylation of p53 at Ser20 may enhance p53's ability to activate p21 expression. Accumulation of the p53 protein in response to treatment with UV was not sucient to eectively activate p21 gene expression in the absence of marked phosphorylation at Ser20. Hence, the regulation of p53 stability and transactivation function appears to be two separate events.
We reasoned that the weak induction of Ser20 phosphorylation and p21 expression in BV173 cells upon treatment with UV may have been caused by celltype speci®c dierences in the kinetics of induction and/or the response of dierent cell lines to dierent sources of DNA damage. To clarify this issue, we examined the relationship between IR-and UVinduced Ser20 phosphorylation and p53 transactivation target protein expression in two additional wt p53-containing cell lines, A549 and MCF7. Total protein was isolated from nontreated cells and IR-or UVtreated cells at 6 and 12 h post-treatment, respectively, and analysed by Western blotting for the induction of total p53 protein by DO-1 antibody and for the expression of p21 and Mdm-2 protein. Roughly equivalent amounts of p53 protein were also immunoprecipitated under nonreducing conditions from the aforementioned total protein extracts and subjected to electrophoresis on a nonreducing SDS ± PAGE gel. The electrophoresed samples were transferred to nitrocellulose membrane and analysed by Western blotting for the expression of total p53 protein by DO-1 antibody or p53 phosphorylated at Ser20 by PAbSer20P antibody. As shown in Figure 3 , p53 protein expression ) induces phosphorylation of p53 at Ser20. (a) BV173 cells (p53 wt) were subjected to treatment with IR or UV. Three hours after treatment, total protein was extracted, fractionated by SDS ± PAGE and analysed for the expression of total p53 protein by DO-1 antibody or for the expression of p21 protein. (b) After treatment with IR or UV, total RNA was extracted from BV173 cells and analysed for p21 mRNA expression by Northern blotting. Expression was quanti®ed by PhosphorImager, and the p21 mRNA levels were normalized to those of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The ratio of p21 to GAPDH for untreated cells was designated as 1, and the fold of p21 induction in IR-or UV-treated cells was indicated under each lane. (c) At dierent time periods after irradiation with IR or UV, total protein was extracted from treated or control BV173 cells under nonreducing conditions. The p53 protein from the same amount of total protein was immunoprecipitated. After centrifugation and washing, the precipitates were eluted in nonreducing sample buer, fractionated by SDS ± PAGE and analysed by Western blotting probed with either DO-1 or PAbSer20P. (d) Phosphoserine 20 Western-blot results from (c) were quanti®ed by densitometry and graphed. Levels of Ser20 phosphorylation were calculated as the fraction of Ser20-phosphorylated protein detected (PAbSer20P) relative to total p53 protein detected (DO-1), and were expressed as the percentage of phosphorylation relative to the peak value. (e) Total protein was extracted from IR-treated or control (C) BV173 cells under nonreducing conditions. P53 protein was immunoprecipitated, fractionated by SDS ± PAGE and analysed by Western blotting probed with either DO-1 or PAbSer20P. C 5X denotes a ®vefold increment in loading of the basal p53 protein from untreated cells was stabilized in each cell line in response to treatment with IR and UV. A strong induction of p21 and Mdm-2 protein expression was elicited in each cell line in response to IR treatment (Figure 3) . However, the induction of p21 and Mdm-2 protein expression by UV occurred only in MCF7 and A549 cells. Consistently, the phosphorylation of p53 at Ser20 correlated with the induction of p21 and Mdm-2 expression in each cell line.
Discussion
In this study, we analysed the state of Ser20 phosphorylation and its impact on downstream target gene expression in four cell lines after treatment with IR or UV. Similar to the observations of Shieh et al. (1999) , we found that mutant p53 in IR-treated CEM cells could be phosphorylated at Ser20. However, this event is apparently ineective in enhancing p53 transactivation, because p53 needs to bind DNA in order to function as a transcription factor, and mutant p53 in CEM cells is incapable of binding DNA. IRinduced phosphorylation at Ser20 successfully enhanced p21 and Mdm-2 expression in the three wt p53-containing cell lines BV173, MCF7 and A549. The dierences in expression of p53 target proteins may re¯ect cell-type speci®c dierences in induction. Alternatively, the kinetics of induction may vary between these proteins. Intriguingly, Ser20 phosphorylation occurred as a cell line-dependent response to UV. UV failed to induce marked Ser20 phosphorylation in CEM and BV173 cells but strongly induced Ser20 phosphorylation in MCF7 and A549 cells. This result suggests that IR and UV utilize dierent signal transduction pathways leading to p53 modi®cation. Nevertheless, the status of Ser20 phosphorylation in UV-treated cells correlated with p21 and Mdm-2 induction, functionally linking Ser20 phosphorylation to p53 transactivation function in vivo.
Our investigation contributes to the emerging picture of p53 protein regulation by DNA damage-induced phosphorylation. Cellular DNA damage caused by treatment with IR or UV has been reported to result in the phosphorylation of p53 in vivo at Ser6 (Higashimoto et al., 2000) , Ser9 (Higashimoto et al., 2000) , Ser15 (Siliciano et al., 1997; Shieh et al., 1997) , Thr18 (Dumaz et al., 1999; Sakaguchi et al., 2000) , Ser20 Chehab et al., 1999 , and this study), Ser33 and Ser37 Shieh et al., 1999) . In contrast, the phosphorylation of p53 at Ser392 has been reported to occur in response to treatment with UV, but not IR, in two cell lines (RKO and F9) tested (Kapoor and Lozano, 1997; Lu et al., 1998) . Based on our observation of cell line-dependent phosphorylation of Ser20 by UV, it would be interesting to know whether Ser392 phosphorylation in response to treatment with IR is also cell linedependent. Functionally, site-speci®c phosphorylation has been demonstrated to bestow distinct eects on p53, including enhanced protein stability (Siliciano et al., 1997; Shieh et al., 1997; Chehab et al., 1999; Unger et al., 1999) , sequence-speci®c DNA binding (Watthew et al., 1998; Woo et al., 1998) , oligomerizatioan and cellular apoptosis (Bulavin et al., 1999; Unger et al., 1999) . Our ®ndings suggest that the phosphorylation of p53 at Ser20, in response to irradiation-induced DNA damage in vivo, employs distinct signal transduction pathways for Ser20 phosphorylation, enhances the transactivation function of p53 for p21 and Mdm-2, and is dispensable for p53 protein stability.
Our ®ndings correlating Ser20 phosphorylation to transactivation function are supported by the observation that Ser20 phosphorylation abridges the interaction of p53 with Mdm-2 (Chehab et al., 1999; Unger et al., 1999 ; Jabbur and Zhang, unpublished results), a protein that acts as a negative regulator of p53 transactivation. Moreover, the transcriptional activity of a nonphosphorylation-mimicking p53 mutant at Ser20 has been shown to be more sensitive than that of wt p53 to inhibition by Mdm-2 (Unger et al., 1999) . Finally, the expression of Chk2 kinase, which phosphorylates p53 at Ser20, results in G 1 arrest of cells in a p53 transcription-dependent manner (Chehab et al., 2000) and enhances the expression of p21 (Hirao et al., 2000) . Hence, it follows that DNA damageinduced phosphorylation of p53 at Ser20 by the kinase Chk2 abridges the interaction of p53 with Mdm-2, facilitating and possibly enhancing the interaction of p53 with members of the basal transcription machinery and/or other transcriptional coactivators, ultimately enhancing the transactivation potential of p53.
Our observation that the p53 protein was stabilized in the absence of Ser20 phosphorylation in UV-treated BV173 cells supports the notion that Ser20 phosphorylation is not a critical modulator of p53 stability in vivo, although it weakens the interaction of p53 with Mdm-2 (Ashcroft et al., 1999; Chehab et al., 1999; Unger et al., 1999; Jabbur and Zhang, unpublished results) . Recent reports, some con¯icting, suggest that the stabilization of p53 is a complex process involving numerous regions on the p53 and Mdm-2 proteins. The binding of p53 by Mdm-2 has been shown to lead to p53 degradation (Haupt et al., 1997; Kubbutat et al., 1997) . Mdm-2 may contribute to this process by ubiquitinating p53 in vivo, since Mdm-2 can act as a ubiquitin ligase ES for p53 in vitro (Honda et al., 1997) . Alternatively, Mdm-2 binding and Mdm-2- ) cells, all containing endogenous wt p53, were treated with IR or UV. Six hours after IR treatment, or 12 h after UV treatment, total protein was extracted under nonreducing conditions, fractionated by SDS ± PAGE and analysed for the expression of total p53, p21 or Mdm-2 protein. Alternatively, roughly equivalent amounts of p53 protein were immunoprecipitated, eluted in nonreducing sample buer, fractionated by SDS ± PAGE and analysed by Western blotting probed with either DO-1 or PAbSer20P antibody mediated p53 degradation have been shown to be two separate events (Kubbutat et al., 1998) . Finally, studies have shown regions other than the transactivation domain of p53 to be required for the ecient degradation of p53 (Kubbutat et al., 1998; Gu et al., 2000) . Conceivably, the interaction of Mdm-2 with p53 results in at least two functional outcomes aecting the transactivation function and stability of p53. Hence, UV treatment may induce modi®cations of other regions of p53 and/or Mdm-2, resulting in the stability of p53 in the absence of Ser20 phosphorylation. We observed the phosphorylation of p53 at Ser15 in BV173 cells exposed to treatment with IR or UV (data not shown), a modi®cation that has been shown to contribute to p53 stability by disrupting the interaction of p53 with Mdm-2 . Moreover, the phosphorylation of Mdm-2 by DNA-PK (Mayo et al., 1997) , ATM (Khosravi et al., 1999) and Chk2 (Hirao et al., 2000) may stabilize p53 in vivo, since Mdm-2 phosphorylation has been shown to attenuate the interaction of p53 with Mdm-2 in vitro (Mayo et al., 1997; Khosravi et al., 1999) .
It is clear that the regulation of p53 by phosphorylation is a complex process. This complexity is compounded by the possibility that stress-induced phosphorylation and dephosphorylation at dierent sites on p53 may exert cooperative or antagonistic eects on p53 protein function. For example, the phosphorylation of p53 at Ser15, Ser20 and Ser37 has been shown to disrupt the interaction of p53 with Mdm-2 Chehab et al., 1999; Unger et al., 1999; Jabbur and Zhang, manuscript in preparation) , whereas phosphorylation at Ser392 facilitates the oligomerization of p53 . In addition, the phosphorylation of p53 at Ser20, Ser33 and Ser46 enhances cellular apoptotic function (Bulavin et al., 1999; Unger et al., 1999) , while IR-induced dephosphorylation at Ser376 results in increased DNA binding ability (Watthew et al., 1998) . These phosphorylation events may, therefore, have synergistic eects that maximally enhance p53's activity. Our identi®cation of the transactivationenhancing role of Ser20 phosphorylation in response to DNA damage sheds light on the mechanisms through which dierent phosphorylation events are coordinated to control p53 functional regulation and stability in vivo.
Materials and methods

Cell culture
CEM (p53 mutant) and BV173 (p53 wild-type) leukemia cells were maintained in RPMI 1640 medium supplemented with 10% fetal calf serum; MCF7 breast carcinoma (p53 wildtype) cells were maintained in Dulbecco's modi®ed Eagle's medium/F12 medium supplemented with 10% fetal calf serum; A549 lung carcinoma (p53 wild-type) cells were maintained in HAM/F12 medium supplemented with 10% fetal calf serum and 1% glutamine. All cells were propagated in a 378C incubator containing 5% CO 2 .
Generation and evaluation of PAbSer20P antibody
PABSer20P antibody was generated against an N-terminal phosphopeptide (Ser20P) of human p53 (NH 2 -S-Q-E-T-F-[pS]-D-L-W-K-COOH) by Quality Controlled Biochemicals. Antibody was isolated from crude serum and anity-puri®ed by a thiol-coupling gel linked to nonphosphorylated peptide, followed by puri®cation with phosphorylated peptide and elution in 100 mM glycine, pH 2.5 (Quality Controlled Biochemicals). Phosphopeptides used to demonstrate antibody speci®city were generated by Quality Controlled Biochemicals. The peptide sequences were: p53 Ser15P, NH 2 -S-V-E-P-P-L- 
Western blotting, phosphatase treatment and immunoprecipitation analyses
Total cellular protein was extracted in the presence of 10 mM sodium¯uoride and 12.5 mM sodium pyrophosphate (phosphatase inhibitors) with the exception of phosphatase-treated samples, which were treated as previously described (Kobayashi et al., 1998) . Immunoprecipitation of p53 was performed under nonreducing conditions on a rotator overnight at 48C with 20 ml of protein-A agarose and 2 mg of anti-p53 antibody PAb421 (Ab-1, Oncogene Science). Western blot analysis was performed as described previously (Zhang et al., 1994) . Twenty-microgram protein samples transferred to Immobilon membrane (Millipore) were analysed using antibodies against p21 (CP74, provided by Wade Harper of Baylor College of Medicine), Mdm-2 (2A10, provided by Gigi Lozano of the University of Texas-MD Anderson Cancer Center), p53 (DO-1, Oncogene Science) and Ser15 phosphorylated p53 (New England Biolabs). Immunoprecipitated p53 samples were electrophoresed under nonreducing conditions (i.e., in the absence of b-mercaptoethanol), transferred to Hybond ECL membrane and analysed using PAbSer20P (Quality Controlled Biochemicals) or DO-1 antibody. Under these conditions, the antibodies used for immunoprecipitation do not separate into their heavy (52 ± 55 kDa) and light chains, thus avoiding interference in detection of p53 protein. Competition with respective peptide epitopes and PAbSer20P antibody entailed pre-incubation in hybridizing solution for 1 h at 48C.
Northern blot analysis
Total RNA was prepared from transfected cells, and Northern blot analysis was carried out as described previously (Kobayashi et al., 1998) . The 32 P-labeled cDNA probes used were glyceraldehyde-3-phosphate dehydrogenase and p21. Expression of p21 was quanti®ed using ImageQuant software and the STORM PhosphorImager 840 (Molecular Dynamics) and normalized to GAPDH mRNA.
